Welcome to our dedicated page for Centrus Energy news (Ticker: LEU), a resource for investors and traders seeking the latest updates and insights on Centrus Energy stock.
Centrus Energy Corp. supplies nuclear fuel and services for the nuclear power industry. Its recurring news centers on Low-Enriched Uranium sales, separative work units, uranium enrichment, High-Assay, Low-Enriched Uranium, and Technical Solutions work that includes engineering, design, and manufacturing services for government and private-sector customers.
Company updates also cover financial results, revenue guidance, centrifuge manufacturing, enrichment-capacity expansion in Piketon, Ohio, and manufacturing activity in Oak Ridge, Tennessee. Partnership news has addressed engineering, project management, supply-chain coordination, artificial-intelligence tools, and other operational support for uranium-enrichment expansion.
Tradr ETFs launched three first-to-market single-stock leveraged ETFs on Feb 19, 2026: CLSZ (2x short on CleanSpark, Nasdaq: CLSK), LEUX (2x long on Centrus, NYSE: LEU) and COHX (2x long on Coherent, NYSE: COHR).
The Cboe-listed funds seek to deliver ±200% daily performance of each underlying stock. Tradr says its lineup totals 69 leveraged ETFs representing over $2 billion in assets and are accessible through most brokerages.
Centrus Energy (NYSE: LEU) will ring the NYSE Opening Bell on Thursday, February 19, 2026 to mark the launch of a multi‑billion‑dollar expansion of uranium enrichment capacity in Piketon, Ohio.
The project targets large‑scale production of LEU and HALEU, supports national security and advanced reactors, and is expected to create 1,300 Ohio jobs, 430 Tennessee manufacturing jobs, plus thousands of supply positions nationwide.
Tradr ETFs will launch three first-to-market single-stock leveraged ETFs on February 19, 2026, listed on Cboe. The funds aim to deliver ±2x daily exposure: CLSZ (2x short CLSK), LEUX (2x long LEU), and COHX (2x long COHR). Investors are warned of significant leveraged ETF risks.
Centrus Energy (commercial symbol LEU) has partnered with Fluor (FLR) as EPC contractor to advance a multi-billion-dollar expansion of uranium enrichment capacity in Piketon, Ohio. Fluor will lead engineering, procurement, construction and commissioning to support LEU backlog and planned HALEU and centrifuge manufacturing scale-up.
The project supports a $2.3 billion commercial LEU contingent backlog, a planned 12‑metric‑ton annual HALEU capacity expansion, a $900 million DOE HALEU task order, and a $560+ million Oak Ridge manufacturing investment.
Centrus (NYSE: LEU) reported 2025 revenue of $448.7 million, net income of $77.8 million and gross profit of $117.5 million. The company raised unrestricted cash to $2.0 billion, enriched over 1 kg of HALEU UF6 and initiated domestic centrifuge manufacturing.
Centrus disclosed a $2.3 billion contingent LEU backlog, total backlog of $3.8 billion, DOE selection for a $900 million HALEU task order (subject to negotiation) and 2026 revenue guidance of $425–475 million.
Centrus Energy (NYSE: LEU) will webcast its quarterly conference call on Wednesday, February 11, 2026 at 8:30 a.m. ET.
The company will release its Q4 and full-year 2025 earnings after market close on Tuesday, February 10, 2026. The webcast link will be in the Investor Relations section at CentrusEnergy.com, with replay available through February 24, 2026.
Centrus (NYSE: LEU) will expand its Oak Ridge centrifuge manufacturing center, investing more than $560 million and creating nearly 430 new jobs in Anderson County to convert the site into a high-rate manufacturing plant. The expansion supports a larger Ohio enrichment plant and follows DOE funding for centrifuge production in Tennessee. The first centrifuges produced in Tennessee are expected to come online in Ohio in 2029. Tennessee's Nuclear Energy Fund has provided a total of $70 million to support related initiatives.
Centrus Energy (NYSE: LEU) was awarded a $900 million fixed‑price task order from the U.S. Department of Energy to expand its Piketon, Ohio uranium enrichment facility for commercial HALEU production. With Department options, the task order value can reach $1.07 billion. The funding supports a previously announced multi‑billion dollar expansion to add HALEU and additional LEU capacity, with the first new capacity expected online in 2029.
The project is described as supporting thousands of U.S. jobs, including 1,000 construction and 300 new operating jobs in Ohio, new jobs at an Oak Ridge centrifuge plant, and thousands of indirect jobs. Centrus says it has $2.3 billion of LEU purchase commitments contingent on financing and raised $1.2 billion via convertible notes in 2024–2025.
Centrus Energy (NYSE: LEU) has begun domestic centrifuge manufacturing to support commercial low-enriched uranium (LEU) enrichment at Piketon, Ohio, targeting initial commercial capacity online in 2029. The expansion is backed by a $2.3 billion backlog of contingent LEU sales, prior convertible note financings totaling $1.2 billion, a reported cash balance of $1.6 billion as of Sept 30, 2025, and a recently launched $1 billion at-the-market offering. The company is a finalist for Department of Energy task orders (each potentially ~$900 million) for LEU and HALEU production and has a proposed investment partnership with KHNP and POSCO International. The project is expected to create thousands of U.S. jobs, including 1,000 construction and 300 operating roles in Ohio.
Centrus Energy (NYSE: LEU) announced it has started design work for a 150,000 square foot Training, Operations & Maintenance Facility in Piketon, Ohio, to support planned expansion of uranium enrichment capacity.
The project repurposes a largely vacant building at the American Centrifuge Plant, with construction expected to begin early 2026. The facility will include offices, training space, and maintenance bays and could accommodate up to 200 new employees.
Centrus is producing HALEU under a DOE contract and previously announced an expansion expected to create 1,000 construction jobs and 300 operations jobs; the size and scope depend on federal funding decisions and could become a multi‑billion‑dollar private and public investment.